Pharmacoeconomic analysis of stress ulcer prophylaxis for critically ill patients

PharmacoEconomics

Volumn 9, Issue 5, 1996, Pages 455-465

  Schumock, Glen T ^a,e   Lam, Nancy P ^b,c   Winkler, Susan R ^b   Kong, Sheldon Xiaodong ^d  

^a Aspirus Wausau Hospital   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

^d PFIZER INC   (United States)

^e Department of Pharmacy ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIULCER AGENT; CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; MYLANTA; RANITIDINE; SUCRALFATE;

ARTICLE; COST; CRITICAL ILLNESS; DECISION THEORY; GASTROINTESTINAL HEMORRHAGE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; INTRAGASTRIC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PHARMACOECONOMICS; PNEUMONIA; PRIORITY JOURNAL; STRESS ULCER; TREATMENT OUTCOME;

EID: 0029940718     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199609050-00008     Document Type: Article

References (55)

1. Kleiman RL, Adair CG, Ephgrave KS. Stress ulcers: current understanding of pathogenesis and prophylaxis. Drug Intell Clin Pharm 1988; 22: 452-60
2. Schepp W. Stress ulcer prophylaxis: still a valid option in the 1990s? Digestion 1993; 54: 189-99
3. Cook DJ, Laine LA, Guyatt GH, et al. Nosocomial pneumonia and the role of gastric pH. Chest 1991; 100: 7-13
4. Cook DJ, Witt LG, Cook RJ, et al. Stress ulcer prophylaxis in the critically ill: a meta-analysis. Am J Med 1991; 91: 519-27
5. Lacroix J, Infante-Rivard C, Janicek M, et al. Prophylaxis of upper gastrointestinal bleeding in intensive care units: a meta-analysis. Crit Care Med 1989; 17: 862-9
6. Tryba M. Prophylaxis of stress ulcer bleeding: a meta-analysis. J Clin Gastroenterol 1991; 13 Suppl. 2: S44-55
7. Tryba M. Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis: a meta-analysis on efficacy and pneumonia rate. Crit Care Med 1991; 19: 942-9
8. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastro-intestinal bleeding in critically ill patients. N Engl J Med 1994; 330(6): 377-81
9. Ben-Menachem T, Fogel R, Patel RV, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. Ann Intern Med 1994; 121: 568-75
10. Wilcox CM, Spenney JG. Stress ulcer prophylaxis in medical patients: who, what and how much. Am J Gastroenterol 1988; 83(11): 1199-211
11. Finkler SA. The distinction between costs and charges. Ann Intern Med 1982; 96: 102-9
12. Drummond MF, Stoddart GL, Torrance GW. Methods for economic evaluation of health care programmes. Oxford: Oxford University Press, 1990: 41
13. Basso N, Bagarani M, Materia A, et al. Cimetidine and antacid prophylaxis of acute gastrointestinal bleeding in high risk patients. Am J Surg 1981; 141: 339-41
14. Cannon LA, Heiselman D, Gardner W, et al. Prophylaxis of upper gastrointestinal tract bleeding in mechanically ventilated patients: a randomized study comparing the efficacy of sucralfate, cimetidine and antacids. Arch Intern Med 1987; 147: 2101-6
15. Driks MR, Craven DR, Celli BR, et al. Nosocomial pneumonia in intubated patients randomized to sucralfate versus antacids and/or histamine type 2 blockers: the role of gastric colonization. N Engl J Med 1987; 317: 1376-82
16. Fabian TC, Boucher BA, Croce MA, et al. Pneumonia and stress ulceration in severely injured patients: a prospective evaluation of the effects of stress ulcer prophylaxis. Arch Surg 1993; 1128: 185-92
17. Friedman CJ, Oblinger MJ, Suratt PM, et al. Prophylaxis of upper gastrointestinal hemorrhage in patients requiring mechanical ventilation. Crit Care Med 1982; 10: 316-9
18. Garcia-Labattut A, Rodriquez-Munoz S, Gobernado-Serraro M, et al. Sucralfate versus cimetidine in the stress bleeding prophylaxis [abstract]. Intensive Care Med 1990; 16 Suppl. 1: S19
19. Halloran LG, Zfass AM, Gayle WE, et al. Prevention of acute gastrointestinal complications after severe head injury: a controlled trial of cimetidine prophylaxis. Am J Surg 1980; 139: 44-8
20. Kappstein I, Schulgen G, Friedman TH, et al. Incidence of pneumonia in mechanically ventilated patients treated with sucralfate or cimetidine as prophylaxis for stress bleeding: bacterial colonization of the stomach. Am J Med 1991; 91 Suppl. 2A: 125S-31S
21. Khan F, Parekh A, Patel S, et al. Results of gastric neutralization with hourly antacids and cimetidine in 320 intubated patients with respiratory failure. Chest 1981; 79: 409-19
22. Lacroix J, Infante-Rivard C, Gauthier M, et al. Upper gastrointestinal tract bleeding acquired in a pediatric intensive care unit: prophylaxis trial with cimetidine. J Pediatr 1986; 108: 1015-8
23. Laggner A, Lenz K, Base W, et al. Prevention of upper gastro-intestinal bleeding in long-term ventilated patients. Am J Med 1989; 86: 81-4
24. Lamothe PH, Rao E, Serra AJ, et al. Comparative efficacy of cimetidine, famotidine, ranitidine and Mylanta in postoperative stress ulcers. Gastroenterology 1991; 100: 1515-20
25. Luk GD, Summer WR, Messersmith JF, et al. Cimetidine and antacid in prophylaxis of acute gastrointestinal bleeding: a randomized, double-blind, controlled study [abstract]. Gastroenterology 1982; 82: 1121
26. Macdougall BRD, Bailey RJ, Williams R. H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Lancet 1977; 1: 617-9
27. Martin LF, Booth FVM, Karlstadt RG, et al. Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med 1993; 21 (1): 19-20
28. Priebe HJ, Skillman JJ, Bushnell LS, et al. Antacid versus cimetidine in preventing acute gastrointestinal bleeding. N Engl J Med 1980; 302: 426-30
29. Ryan P, Dawson J, Teres D, et al. Nosocomial pneumonia during stress ulcer prophylaxis with cimetidine and sucralfate. Arch Surg 1993; 128: 1353-7
30. Stotert JC, Siminowitz DA, Dellinger EP, et al. Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill. Ann Surg 1980; 192: 169-74
31. Tryba M, Zevounou F, Torok M, et al. Prevention of acute stress bleeding with sucralfate, antacids or cimetidine: a controlled study with pirenzepine as a basic medication. Am J Med 1985; 79 Suppl. 2C: 55-61
32. Weigelt JA, Aurbakken CM, Gewertz BL, et al. Cimetidine vs antacid in prophylaxis for stress ulceration. Arch Surg 1981; 116: 597-601
33. Zinner MJ, Zuidema GD, Smith PL, et al. The prevention of upper gastrointestinal tract bleeding in patients in an intensive care unit. Surg Gynecol Obstet 1981; 153: 214-20
34. Borrero E, Banks S, Margolis I, et al. Comparison of antacid and sucralfate in the prevention of gastrointestinal bleeding in patients who are critically ill. Am J Med 1985; 79 Suppl. 2C: 62-4
35. Borrero E, Ciervo J, Chang JB. Antacid vs sucralfate in preventing acute gastrointestinal tract bleeding in abdominal aortic surgery. Arch Surg 1986; 121: 810-2
36. Bresalier RS, Grenell JH, Cello JP, et al. Sucralfate suspension versus titrated antacid for the prevention of acute stress-related gastrointestinal hemorrhage in critically ill patients. Am J Med 1987; 83 Suppl. 3B: 110-6
37. Hastings PR, Skillman JJ, Bushnell LS, et al. Antacid titration in the prevention of acute gastrointestinal bleeding. N Engl J Med 1978; 298: 1041-5
38. Israsena S, Anantapanpong S, Kladcharoen N, et al. Sucralfate versus antacid in the prevention of stress ulcer bleeding on mechanical ventilation. J Med Assoc Thai 1987; 70: 678-81
39. McAlhany JC, Czaja AJ, Pruitt BA. Antacid control of complications of acute gastrointestinal disease after burns. J Trauma 1976; 16: 645-9
40. Mundinger GH, Hays A, Allo M, et al. Effects of meciadanol and sucralfate as compared with antacid titration regimen on prevention of acute gastrointestinal hemorrhage in postoperative intensive care patients. Surg Forum 1985; 121-3
41. Pinilla JC, Oleniuk FH, Reed D, et al. Does antacid prophylaxis prevent upper gastrointestinal bleeding in critically ill patients? Crit Care Med 1985; 13: 646-50
42. Tryba M. Side effects of stress bleeding prophylaxis. Am J Med 1987; 85 Suppl. 6A: 85-93
43. Apte NM, Karnad DP, Medhekar TP, et al. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial. Crit Care Med 1992; 20: 590-693
44. Eddleston J, Vohra A, Scott P, et al. A comparison of the frequency of stress ulceration and secondary pneumonia in sucralfate- or ranitidine-treated intensive care unit patients. Crit Care Med 1991; 19: 1491-6
45. Mahul P, Auboyer C, Jospe R, et al. Prevention of nosocomial pneumonia in intubated patients: respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis. Intensive Care Med 1992; 18: 20-5
46. 1994 Red Book. Montvale (NJ): Medical Economics Data, Inc., 1994
47. Copley-Merriam C, Lair TJ. Valuation of medical resource units collected in health economic studies. Clin Ther 1994; 16: 553-68
48. Babbi E. The practice of social research. 6th ed. Belmont (CA); Woodsworth Publishing Company, 1992: 486
49. Top 200. Am Druggist 1994 Feb: 27-34
50. Lam NP, Schumock GT, Winkler S, et al. Pharmacoeconomic evaluation of drug therapy for stress ulcer prophylaxis [abstract]. Gastroenterology 1995; 108(4): A22
51. L'Abbe KA, Detsky AS, O'Rourke K. Meta-analysis in clinical research. Ann Intern Med 1987; 107: 224-33
52. Cook TD, Campbell ST. Quasi-experimental design & analysis issues for field settings. Boston (MA): Houghtron Miffin Company, 1979: 37-94
53. Tryba M, Mantey-Stiers F. Antibacterial activity of sucralfate in human gastric juice. Am J Med 1987; 83 Suppl. 3B: 125-7
54. Prod'hom G, Leuenberger P, Koerfer J, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. Ann Intern Med 1994; 120: 653-62
55. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA 1996; 275 (4): 308-14